| Literature DB >> 22203735 |
Frank S Ong1, Chentao X Lin, Duncan J Campbell, Derick Okwan-Duodu, Xu Chen, Wendell-Lamar B Blackwell, Kandarp H Shah, Romer A Gonzalez-Villalobos, Xiao Z Shen, Sebastien Fuchs, Kenneth E Bernstein.
Abstract
-Angiotensin-converting enzyme (ACE) is composed of the N- and C-terminal catalytic domains. To study the role of the ACE domains in the inflammatory response, N-knockout (KO) and C-KO mice, models lacking 1 of the 2 ACE domains, were analyzed during angiotensin II-induced hypertension. At 2 weeks, N-KO mice have systolic blood pressures that averaged 173±4.6 mm Hg, which is more than 25 mm Hg higher than the blood pressures observed in wild-type or C-KO mice (146±3.2 and 147±4.2 mm Hg). After 3 weeks, blood pressure differences between N-KO, C-KO, and wild-type were even more pronounced. Macrophages from N-KO mice have increased expression of tumor necrosis factor α after stimulation with either lipopolysaccharide (about 4-fold) or angiotensin II (about 2-fold), as compared with C-KO or wild-type mice. Inhibition of the enzyme prolyl oligopeptidase, responsible for the formation of acetyl-SerAspLysPro and other peptides, eliminated the blood pressure difference and the difference in tumor necrosis factor α expression between angiotensin II-treated N-KO and wild-type mice. However, this appears independent of acetyl-SerAspLysPro. These data establish significant differences in the inflammatory response as a function of ACE N- or C-domain catalytic activity. They also indicate a novel role of prolyl oligopeptidase in the cytokine regulation and in the blood pressure response to experimental hypertension.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22203735 PMCID: PMC3266456 DOI: 10.1161/HYPERTENSIONAHA.111.180844
Source DB: PubMed Journal: Hypertension ISSN: 0194-911X Impact factor: 10.190